Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option in Connection With Preferred Stock Offering
[Marketwired] – Peregrine Pharmaceuticals, Inc. , announced today that the underwriters of its underwritten public offering of its 10.50% Series E Convertible Preferred Stock have partially exercised their option to cover … moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]